Genmab Announces Positive Topline Results in Phase III ANDROMEDA Study of Daratumumab in Light-chain (AL) Amyloidosis

NEXT STORY
Caladrius Biosciences Closes $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
PREV STORY
White Oil Market To Reach USD 6.4 Billion By 2027 | Reports and Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apexigen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

author_avatar
NASDAQ Market News

CorMedix Inc. Announces a Change to its Senior Leadership

author_avatar
NASDAQ Market News

Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa.

Results of Phase 1 Safety Study of SBP-101 for Pancreatic Ductal AdenocarcinomaPancreasFest is an ...

author_avatar
NASDAQ Market News